News for Abeona Therapeutics Inc. (ABEO)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

On December 31, 2024, Western Standard LLC (Trades, Portfolio) made a significant move by acquiring an additional 138,200 shares of First Financial Northwest In

On December 31, 2024, Rosalind Advisors, Inc. (Trades, Portfolio) made a significant move by adding 412,087 shares of OptiNose Inc. (NASDAQ: OPTN) to its portfo

On December 31, 2024, Rosalind Advisors, Inc. (Trades, Portfolio) significantly increased its investment in InspireMD Inc. by acquiring an additional 7,419,918

CLEVELAND, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. ( ABEO) today announced it has granted equity awards to new non-executive employees who

On January 29, 2025, Mark Alvino, a Director at Abeona Therapeutics Inc (ABEO), sold 4,000 shares of the company. Following this transaction, the insider now ow

Abeona Therapeutics Inc.'s promising gene therapy for RDEB, potential FDA approval, undervalued stock, and key risks. Click for our ABEO stock update.

**media[503338]**

On November 12, 2024, Rosalind Advisors, Inc. (Trades, Portfolio) made a strategic move by acquiring 2,100,840 shares of Neuraxis Inc (NRXS). This transaction,

CLEVELAND, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. ( ABEO) today announced it has granted equity awards to new non-executive employees who

Overview of Recent Transaction On October 31, 2024, Rosalind Advisors, Inc. (Trades, Portfolio), a prominent investment firm, executed a significant transaction

Westford, USA, Sept. 12, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Global Gene Therapy Market will reach a value of USD 38.34 Billion by 2031,...

Loading... Loading... Shares of Nucor Corporation NUE fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial ...

Loading... Loading... Shares of Hibbett, Inc. HIBB rose sharply in today's pre-market trading after the company agreed to be acquired by JD Sports Fashion for ...

Voyager Therapeutics investors need to be patient as the biotech targets hard to treat Alzheimer's and Parkinson's. Read why the best days are ahead for VYGR stock.

/PRNewswire/ -- DelveInsight's Mucopolysaccharidosis Market Insights report includes a comprehensive understanding of current treatment practices,...

SkyQuest's Plasma Therapy market report is excellent information for individuals interested in gaining insight into the valuable data, trends, and...

Explore safer techniques & vital info on shorting OTC stocks in a market often seen as the stock market's wild west. Dive into the world of shorting.

GuruFocus Article or News written by insider and the topic is about: